Contrasting Hyperfine (NASDAQ:HYPR) & Echo Therapeutics (OTCMKTS:ECTE)
Contrasting Hyperfine (NASDAQ:HYPR) & Echo Therapeutics (OTCMKTS:ECTE)
Echo Therapeutics (OTCMKTS:ECTE – Get Rating) and Hyperfine (NASDAQ:HYPR – Get Rating) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, dividends, profitability, earnings, analyst recommendations, valuation and institutional ownership.
Echo Therapeutics（OTCMKTS: ECTE — 獲取評級）和 Hyperfine（納斯達克股票代碼：HYPR — 獲取評級）都是醫療公司，但哪家更勝一籌？我們將根據兩家企業的風險、股息、盈利能力、收益、分析師建議、估值和機構所有權的強度對比這兩家企業。
Valuation & Earnings
估值與收益
This table compares Echo Therapeutics and Hyperfine's revenue, earnings per share (EPS) and valuation.
該表比較了Echo Therapeutics和Hyperfine的收入、每股收益（EPS）和估值。
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Echo Therapeutics | N/A | N/A | N/A | N/A | N/A |
| Hyperfine | $1.50 million | 40.46 | -$64.85 million | ($3.59) | -0.24 |
| 總收入 | 價格/銷售比率 | 淨收入 | 每股收益 | 市盈率 | |
| Echo Therap | 不適用 | 不適用 | 不適用 | 不適用 | 不適用 |
| 超精細 | 150 萬美元 | 40.46 | -6,485 萬美元 | (3.59 美元) | -0.24 |
Echo Therapeutics has higher earnings, but lower revenue than Hyperfine.
Echo Therapeutics的收益更高，但收入低於Hyperfine。
Insider & Institutional Ownership
內幕和機構所有權
Profitability
盈利能力
This table compares Echo Therapeutics and Hyperfine's net margins, return on equity and return on assets.
該表比較了Echo Therapeutics和Hyperfine的淨利潤率、股本回報率和資產回報率。
| Net Margins | Return on Equity | Return on Assets | |
| Echo Therapeutics | N/A | N/A | N/A |
| Hyperfine | -1,479.40% | -54.01% | -49.87% |
| 淨利潤 | 股本回報率 | 資產回報率 | |
| Echo Therap | 不適用 | 不適用 | 不適用 |
| 超精細 | -1,479.40% | -54.01% | -49.87% |
Analyst Ratings
分析師評級
This is a breakdown of current ratings and recommmendations for Echo Therapeutics and Hyperfine, as provided by MarketBeat.
這是MarketBeat提供的Echo Therapeutics和Hyperfine的當前評級和推薦的明細。
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Echo Therapeutics | 0 | 0 | 0 | 0 | N/A |
| Hyperfine | 0 | 1 | 2 | 0 | 2.67 |
| 賣出評級 | 持有評級 | 買入評級 | 強勁的買入評級 | 評分分數 | |
| Echo Therap | 0 | 0 | 0 | 0 | 不適用 |
| 超精細 | 0 | 1 | 2 | 0 | 2.67 |
Hyperfine has a consensus price target of $4.30, suggesting a potential upside of 400.00%. Given Hyperfine's higher possible upside, analysts plainly believe Hyperfine is more favorable than Echo Therapeutics.
Hyperfine的共識目標股價爲4.30美元，這表明潛在的上漲空間爲400.00％。鑑於Hyperfine可能有更高的上行空間，分析師顯然認爲Hyperfine比Echo Therapeutics更有利。
Summary
摘要
Hyperfine beats Echo Therapeutics on 5 of the 8 factors compared between the two stocks.
與兩隻股票相比，Hyperfine在8個因素中有5個擊敗了Echo Therapeutics。
About Echo Therapeutics
關於 Echo Therape
(Get Rating)
（獲取評級）
Echo Therapeutics, Inc. is a medical device company, which engages in the development of non-invasive, and wireless continuous glucose monitoring system for use in the diabetes outpatient market. It offers needle-free skin preparation device as a platform technology that allows for enhanced skin permeation enabling extraction of analytes, such as glucose and delivery of topical pharmaceuticals. The company was founded in 1989 and is headquartered in Iselin, NJ.
Echo Therapeutics, Inc. 是一家醫療設備公司，致力於開發用於糖尿病門診市場的非侵入性和無線連續血糖監測系統。它提供無針皮膚製備設備作爲平臺技術，可增強皮膚滲透性，從而能夠提取葡萄糖等分析物並輸送外用藥物。該公司成立於1989年，總部位於新澤西州伊瑟林。
About Hyperfine
關於超精細
(Get Rating)
（獲取評級）
Hyperfine, Inc. provides imaging, monitoring, and magnetic resonance imaging products. It offers Swoop Portable MR imaging system to address an unmet need in point-of-care medical imaging through a combination of hardware and software services. The company was incorporated in 2014 and is based in Guilford, Connecticut.
Hyperfine, Inc. 提供成像、監控和磁共振成像產品。它提供Swoop Portable MR成像系統，通過硬件和軟件服務的組合來滿足牀旁醫學成像中未得到滿足的需求。該公司成立於2014年，總部位於康涅狄格州吉爾福德。
Receive News & Ratings for Echo Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Echo Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
接收 Echo Therapeutics Daily 的 -在下面輸入您的電子郵件地址，通過Marketbeat.com的免費每日電子郵件時事通訊接收Echo Therapeutics及相關公司最新新聞和分析師評級的簡明每日摘要。
譯文內容由第三人軟體翻譯。